Cipla
Dr. Sudam Sinare is an accomplished professional in the pharmaceutical industry, currently serving as Associate Director of API R&D at Cipla since January 2013. With a robust background in process development and optimization for active pharmaceutical ingredients (APIs), Dr. Sinare leads a team to ensure the timely completion of projects while developing novel processes and polymorphs to create intellectual property assets. Prior experience includes roles at Eisai Pharmaceutical Science & Technology as a Principal Research Scientist, focusing on process development for new chemical entities, and at Glenmark Generics Ltd. as a Research Officer, where commercialization and validation of synthetic processes was emphasized. Dr. Sinare holds a PhD in Chemistry from the CSIR-Indian Institute of Chemical Technology and an MSc in Organic Chemistry from the University of Pune.
This person is not in any teams
This person is not in any offices
Cipla
19 followers
Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.